| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Mar 4, 2021 | Mar 8, 2021 | Kalaris Therapeutics, Inc. | Director | Sell | 20.0 | -97,689 | -10.32% | ✓ | $3.3M |
| Mar 1, 2021 | Mar 3, 2021 | Kalaris Therapeutics, Inc. | Director | Sell | 27.5 | -52,267 | -5.23% | ✓ | $2M |
| Feb 19, 2021 | Feb 23, 2021 | Kalaris Therapeutics, Inc. | Director | Sell | 32.5 | -31,902 | -3.10% | ✓ | $1.3M |
| Feb 18, 2021 | Feb 19, 2021 | Kalaris Therapeutics, Inc. | Director | Sell | 45.0 | -6,757 | -0.65% | ✓ | $275.4K |
| Feb 16, 2021 | Feb 18, 2021 | Kalaris Therapeutics, Inc. | Director | Sell | 42.5 | -11,385 | -1.09% | ✓ | $469.3K |